Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for 2019 (699 publications)

no pagination
Kantidze OL, Gurova KV, Studitsky VM, Razin SV. The 3D Genome as a Target for Anticancer Therapy. Trends in Molecular Medicine. 2019 Oct 31;.
Saxena R, Klochkova A, Murray MG, Kabir MF, Samad S, Beccari T, Gang J, Patel K, Hamilton KE, Whelan KA. Roles for Autophagy in Esophageal Carcinogenesis: Implications for Improving Patient Outcomes. Cancers. 2019 Oct 31;11(11).   PMCID: PMC6895837
Fleisher L, Bass SB, Shwarz M, Washington A, Nicholson A, Alhajji M, Geynisman DM, Maurer L, Greener J, Kenny C. Using theory and user-centered design in digital health: The development of the mychoice communication tool to prepare patients and improve informed decision making regarding clinical trial participation. Psychooncology. 2019 Oct 26;.
Di RorĂ  AG, Bocconcelli M, Ferrari A, Terragna C, Bruno S, Imbrogno E, Beeharry N, Robustelli V, Ghetti M, Napolitano R, Chirumbolo G, Marconi G, Papayannidis C, Paolini S, Sartor C, Simonetti G, Yen TJ, Martinelli G. Synergism through WEE1 and CHK1 inhibition in acute lymphoblastic leukemia. Cancers. 2019 Oct 25;11(11).   PMCID: PMC6895917
Wiese D, Stroup AM, Crosbie A, Lynch SM, Henry KA. The Impact of Neighborhood Economic and Racial Inequalities on the Spatial Variation of Breast Cancer Survival in New Jersey. Cancer Epidemiol Biomarkers Prev. 2019 Oct 24;28(12):1958-67.
Barton M, Santucci-Pereira J, Vaccaro OG, Nguyen T, Su Y, Russo J. BC200 overexpression contributes to luminal and triple negative breast cancer pathogenesis. BMC cancer. 2019 Oct 23;19(1):994.   PMCID: PMC6813071
Bishnoi R, Sousa GL, Contet A, Day CJ, Hou CD, Profitt LA, Singla D, Jennings MP, Valentine AM, Povelones M, Baxter RH. Solution structure, glycan specificity and of phenol oxidase inhibitory activity of Anopheles C-type lectins CTL4 and CTLMA2. Sci Rep. 2019 Oct 23;9(1):15191.   PMCID: PMC6811590
Somarelli JA, Gardner H, Cannataro VL, Gunady EF, Boddy AM, Johnson NA, Fisk JN, Gaffney SG, Chuang JH, Li S, Ciccarelli FD, Panchenko AR, Megquier K, Kumar S, Dornburg A, DeGregori J, Townsend JP. Molecular biology and evolution of cancer: from discovery to action. Molecular biology and evolution. 2019 Oct 23;.
Ghatalia P, Gordetsky J, Kuo F, Dulaimi E, Cai KQ, Devarajan K, Bae S, Naik G, Chan TA, Uzzo R, Hakimi AA, Sonpavde G, Plimack E. Correction to: Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma. Journal for immunotherapy of cancer. 2019 Oct 22;7(1):273.   PMCID: PMC6806554
Tao Q, Tamura K, Mello B, Kumar S. Reliable confidence intervals for RelTime estimates of evolutionary divergence times. Molecular biology and evolution. 2019 Oct 22;.
Langford TD, Gordon J. Perspectives on HIV and other age-related neurological diseases. Journal of neurovirology. 2019 Oct 21;25(5):619-21.   PMCID: PMC6858590
Bayarmagnai B, Perrin L, Pourfarhangi KE, Grana X, Tuzel E, Gligorijevic B. Invadopodia-mediated ECM degradation is enriched in the G1 phase of the cell cycle. Journal of cell science. 2019 Oct 18;132(20).   PMCID: PMC6826011
O'Malley DM, Davis SN, Devine KA, Sullivan B, Bator A, Clemow L, Ferrante JM, Findley PA, Miller SM, Hudson SV. Development and usability testing of the e-EXCELS tool to guide cancer survivorship follow-up care. Psychooncology. 2019 Oct 18;.
Galloway TJ, Ridge JA. Treatment of Head and Neck Cancer-Sometimes, Less Is More. JAMA otolaryngology-- head & neck surgery. 2019 Oct 17;.
Wang P, Gamero AM, Jensen LE. IL-36 promotes anti-viral immunity by boosting sensitivity to IFN-alpha/beta in IRF1 dependent and independent manners. Nat Commun. 2019 Oct 16;10(1):4700.   PMCID: PMC6795910
Lee CT, Lehrer EJ, Aphale A, Lango M, Galloway TJ, Zaorsky NG. Surgical excision, Mohs micrographic surgery, external-beam radiotherapy, or brachytherapy for indolent skin cancer: An international meta-analysis of 58 studies with 21,000 patients. Cancer. 2019 Oct 15;125(20):3582-94.
Westin SN, Sill MW, Coleman RL, Waggoner S, Moore KN, Mathews CA, Martin LP, Modesitt SC, Lee S, Ju Z, Mills GB, Schilder RJ, Fracasso PM, Birrer MJ, Aghajanian C. Safety lead-in of the MEK inhibitor trametinib in combination with GSK2141795, an AKT inhibitor, in patients with recurrent endometrial cancer: An NRG Oncology/GOG study. Gynecol Oncol. 2019 Oct 15;155(3):420-8.   PMCID: PMC6922584
Xu W, Puligandla M, Manola J, Bullock AJ, Tamasauskas D, McDermott DF, Atkins MB, Haas NB, Flaherty K, Uzzo RG, Dutcher JP, DiPaola RS, Bhatt RS. Angiogenic Factor and Cytokine Analysis among Patients Treated with Adjuvant VEGFR TKIs in Resected Renal Cell Carcinoma. Clin Cancer Res. 2019 Oct 15;25(20):6098-106.
Zhang Q, Wang HY, Liu X, Nunez-Cruz S, Jillab M, Melnikov O, Nath K, Glickson J, Wasik MA. Cutting Edge: ROR1/CD19 Receptor Complex Promotes Growth of Mantle Cell Lymphoma Cells Independently of the B Cell Receptor-BTK Signaling Pathway. J Immunol. 2019 Oct 15;203(8):2043-8.
Hall KW, Sirk TW, Percec S, Klein ML, Shinoda W. Divining the shape of nascent polymer crystal nuclei. The Journal of chemical physics. 2019 Oct 14;151(14):144901.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications for the year 2019


Last updated on Friday, January 03, 2020